Angelo Corti Selected Research

Infliximab (Remicade)

1/2014	TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab.
10/2012	Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelo Corti Research Topics

Disease

78	Neoplasms (Cancer) 01/2024 - 02/2002
12	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 02/2002
10	Neuroblastoma 01/2019 - 11/2003
9	Inflammation (Inflammations) 10/2022 - 01/2009
8	Melanoma (Melanoma, Malignant) 01/2023 - 05/2003
7	Lymphoma (Lymphomas) 07/2022 - 02/2002
7	Adenocarcinoma 01/2020 - 02/2002
5	Heart Failure 11/2019 - 03/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2008
4	Critical Illness (Critically Ill) 10/2022 - 08/2012
4	Hypertension (High Blood Pressure) 11/2019 - 03/2010
4	Disease Progression 01/2019 - 01/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 08/2023 - 01/2022
3	COVID-19 01/2023 - 10/2021
3	Hypoxia (Hypoxemia) 10/2021 - 11/2011
3	Fibrosarcoma 05/2021 - 05/2016
3	Rheumatoid Arthritis 11/2019 - 06/2006
3	Insulin Resistance 11/2019 - 01/2017
3	Shock 09/2019 - 08/2012
3	Erdheim-Chester Disease 07/2016 - 10/2012
2	Infections 10/2022 - 09/2019
2	Brain Neoplasms (Brain Tumor) 07/2022 - 05/2021
2	Systolic Heart Failure 02/2022 - 01/2013
2	Atherosclerosis 11/2019 - 06/2017
2	Obesity 11/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 02/2016 - 07/2008
2	Multiple Myeloma 01/2016 - 01/2015
2	Vascular Tissue Neoplasms 12/2013 - 12/2013
2	Necrosis 01/2010 - 07/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2010 - 08/2007
1	Leukemia 01/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Multiple Organ Failure (MODS) 10/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022

Drug/Important Bio-Agent (IBA)

48	Peptides (Polypeptides)IBA 01/2023 - 02/2002
41	Chromogranin AIBA 01/2023 - 02/2002
30	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 02/2002
23	LigandsIBA 01/2024 - 01/2004
21	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
19	CytokinesIBA 07/2022 - 08/2002
15	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021 - 08/2002
14	vasostatin IIBA 02/2022 - 03/2006
13	IntegrinsIBA 08/2023 - 01/2004
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2002
11	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2024 - 11/2003
11	Liposomes (Liposome)IBA 01/2019 - 11/2003
9	NGR peptideIBA 07/2022 - 12/2002
8	AntibodiesIBA 01/2019 - 02/2002
7	GoldIBA 08/2023 - 03/2013
6	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2012
5	human CNGRC fusion protein tumor necrosis factor-alphaIBA 11/2020 - 01/2010
5	chromogranin A (344-364)IBA 11/2019 - 10/2012
5	AntigensIBA 01/2017 - 01/2004
4	EnzymesIBA 01/2024 - 08/2007
4	Cyclic PeptidesIBA 08/2023 - 12/2002
4	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2017 - 09/2008
4	Isoaspartic Acid (Isoaspartate)IBA 09/2017 - 09/2008
4	Protein Isoforms (Isoforms)IBA 01/2010 - 02/2002
3	AvidinIBA 01/2024 - 05/2003
3	Biotin (Vitamin H)FDA Link 01/2024 - 05/2003
3	Neuropilin-1IBA 11/2022 - 11/2018
3	ChromograninsIBA 11/2022 - 02/2011
3	AlbuminsIBA 10/2022 - 03/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2015
3	Monoclonal AntibodiesIBA 01/2018 - 01/2011
3	liposomal doxorubicin (Doxil)FDA Link 09/2017 - 11/2003
3	Melphalan (Alkeran)FDA LinkGeneric 09/2011 - 01/2004
3	Arginine (L-Arginine)FDA Link 03/2010 - 09/2008
3	Complementary DNA (cDNA)IBA 10/2004 - 02/2002
2	Proton Pump InhibitorsIBA 01/2023 - 01/2016
2	IronIBA 10/2021 - 11/2015
2	Interleukin-12 (IL 12)IBA 05/2021 - 11/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2013
2	Coloring Agents (Dyes)IBA 11/2018 - 01/2011
2	LipidsIBA 01/2018 - 01/2009
2	Hormones (Hormone)IBA 07/2016 - 12/2010
2	Fibrinolysin FDA Link 01/2016 - 11/2002
2	Infliximab (Remicade)FDA Link 01/2014 - 10/2012
2	ChemokinesIBA 09/2012 - 03/2012
2	vasectrin I (VS I)IBA 09/2012 - 08/2012
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2007 - 08/2002
1	polypeptide CIBA 01/2024
1	Contrast MediaIBA 08/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023
1	IRDye 800CWIBA 01/2023
1	cysteinylglycine (Cys-Gly)IBA 07/2022
1	C-Reactive ProteinIBA 01/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	SaporinsIBA 01/2022
1	lactate dehydrogenase C4IBA 10/2021
1	AlarminsIBA 10/2021
1	CreatinineIBA 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021

Therapy/Procedure

29	Therapeutics 01/2024 - 02/2002
13	Drug Therapy (Chemotherapy) 10/2020 - 08/2002
4	Immunotherapy 07/2022 - 03/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 01/2017
1	Intravesical Administration 08/2023
1	Art Therapy 01/2022